GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amin Pharmaceutical Co (XTEH:AMIN1) » Definitions » Sale Of Business

Amin Pharmaceutical Co (XTEH:AMIN1) Sale Of Business : IRR Mil (TTM As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Amin Pharmaceutical Co Sale Of Business?

Amin Pharmaceutical Co's sale of business for the six months ended in . 20 was IRR0.00 Mil. It means Amin Pharmaceutical Co gained IRR0.00 Mil from selling business. Amin Pharmaceutical Co does not have enough years/quarters to calculate the sale of business for the trailing twelve months (TTM) ended in . 20.

Compared with last quarter (IRR0.00 Mil in . 20 ), Amin Pharmaceutical Co gained the same money from selling business in . 20 (IRR0.00 Mil).


Amin Pharmaceutical Co Sale Of Business Historical Data

The historical data trend for Amin Pharmaceutical Co's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amin Pharmaceutical Co Sale Of Business Chart

Amin Pharmaceutical Co Annual Data
Trend
Sale Of Business

Amin Pharmaceutical Co Semi-Annual Data
Sale Of Business

Amin Pharmaceutical Co Sale Of Business Calculation

The amount earned to sell business.



Amin Pharmaceutical Co Sale Of Business Related Terms

Thank you for viewing the detailed overview of Amin Pharmaceutical Co's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Amin Pharmaceutical Co (XTEH:AMIN1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Abolfazl Street, Bostan Heftam West Alley, No. 4, 2nd floor, Marzdaran, Tehran, IRN
Amin Pharmaceutical Co is engaged in the manufacturing of pharmaceutical products, chemical drugs, herbal medicines, and nutritional supplements. It offers antimicrobials, cardiovascular, antidiabetic, cerebellar, gastrointestinal, antibiotic and antifungal, and hypoglycemic agents among others. It develops drugs in the form of plain and overlaid tablets, hard, and soft capsules, oral drops, syrups, and suspensions. Products offered by the company include Acarbose, Sitagliptin, Fampridine, Ofloxacin, Amiodarone, Ibuprofen, Zolpidem, Bilberry, Thyme, and others. Amin also exports its products to Afghanistan, Kazakhstan, Uzbekistan, and Iraq.

Amin Pharmaceutical Co (XTEH:AMIN1) Headlines

No Headlines